
CJC-1295 / Ipamorelin
A two-component preparation labeled 5 mg CJC-1295 and 5 mg ipamorelin. The exact CJC form awaits supplier documentation.
Pricing to be announcedHM-CJC-1295-IPAMORELIN-5-5Exclusively for laboratory research. Not for human or animal use. Vial sizes are labeled quantities, not administration instructions.
About CJC-1295 / Ipamorelin
This catalog label identifies two components and their stated quantities. Ipamorelin is described in primary literature as a synthetic pentapeptide. CJC-designated materials can differ in their molecular modifications; a blend name alone does not establish whether a drug affinity complex (DAC) is present. The components must be identified separately in the supplier specification.
- Reference identity
- Two-component blend · labeled 5 mg / 5 mg
- This selection
- 5mg / 5mg · HM-CJC-1295-IPAMORELIN-5-5
Scientific references
References describe the named compound. They are not COAs or evidence of testing for a Horizon lot.
Primary literature · PubMed ↗Primary literature · PubMed ↗